Matthew Duffy joins CorMedix board
This article was originally published in Scrip
Executive Summary
CorMedix, a pharmaceutical company developing and commercialising therapeutic products for the prevention and treatment of cardiorenal disease, has appointed Matthew Duffy to its board of directors. Having previously worked for Pfizer, MedImmune, and Lev Pharmaceuticals, Mr Duffy is currently a managing partner and founder of Black Diamond Research which provides consulting services to industry.